The move comes only a few days after FDA laid out a plan that would see it working with the industry and international partners to expedite the development and availability of medical products needed to diagnose, treat, mitigate, and prevent...
The company has received Breakthrough Device Designation from FDA for the Fully Implantable Left Ventricular Assist System (FILVAS).
Abbott Laboratories started off 2020 strong in the cardiovascular space. First the company announced receiving CE mark approval for the Tendyne transcatheter mitral valve implantation system along with winning approval for the CATALYST trial.
In honor of the 40th anniversary of the first human implant of an implantable cardioverter-defibrillator (ICD), we look back at the key moments in ICD history.
QuantuMDx Group Limited and Ontera Inc. are working together on a system to rapidly identify blood stream infection and drug resistance.